The action of CR1-S in AD is still unclear: one possibility is that since CR1-S encodes more C3b/C4b binding sites, CR1-S leads to increased complement activation and inflammation and thereby increases AD risk [104, 113]. The gene discussed is C3; the disease is Alzheimer disease.